trending Market Intelligence /marketintelligence/en/news-insights/trending/bc3z6eieiftucsze1emewq2 content esgSubNav
In This List

Arbutus Biopharma appoints CFO

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Arbutus Biopharma appoints CFO

Arbutus Biopharma Corp. named David Hastings as CFO, effective June 11.

Hastings takes over the CFO role from Koert VandenEnden, Arbutus' interim CFO. Hastings served as CFO and senior vice president of Unilife Corp. from 2015 to 2017 and as its chief accounting officer and treasurer from 2016 to 2017.

Burnaby, British Columbia-based Arbutus Biopharma develops and commercializes treatments for chronic hepatitis B infection.